2nd Global Conference on

Addiction Medicine,
Behavioral Health and Psychiatry

October 21-23, 2021 | Online Conference


About Shenzhen Sciencare Medical Industries Co Ltd

Sciencare Medical has always been committed to the research and development, production and marketing of innovative drugs. Engage with the world's top scientific leaders and doctors, our goal is to further exploring medical research.  In 2003, Sciencare began to develop naltrexone implants.

With decades of continuous research, Sciencare has accumulated rich experience in long-acting sustained-release technology, and has made contributions to the field of Substance Abuse and Mental Illness. And become technology leader in the field of Sustained-release and Naltrexone application.

About Sciencare Naltrexone Implants
Oral naltrexone’s effectiveness as an opioid antagonist has been limited due to poor patient adherence. A long-acting naltrexone formulation may be beneficial. Naltrexone implant developed by Sciencare Medical can be implanted into subcutaneous tissue, targeted for a five-month duration of action in blocking opioid agonist challenge effects in humans. Because of unique innovative patent technology, naltrexone implant takes effect quickly and can be controlled release stably without initial burst release effect. Long-acting naltrexone implant was safe and the main adverse events were mild and reversible.